Molecular markers of neuropsychological functioning and Alzheimer's disease

Melissa Edwards, Valerie Hobson Balldin, James Hall, Sidney O'Bryant

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

Background: The current project sought to examine molecular markers of neuropsychological functioning among elders with and without Alzheimer's disease (AD) and determine the predictive ability of combined molecular markers and select neuropsychological tests in detecting disease presence. Methods: Data were analyzed from 300 participants (n=150, AD and n=150, controls) enrolled in the Texas Alzheimer's Research and Care Consortium. Linear regression models were created to examine the link between the top five molecular markers from our AD blood profile and neuropsychological test scores. Logistical regressions were used to predict AD presence using serum biomarkers in combination with select neuropsychological measures. Results: Using the neuropsychological test with the least amount of variance overlap with the molecular markers, the combined neuropsychological testandmolecular markers was highly accurate in detecting AD presence. Conclusion: This work provides the foundation for the generation of a point-of-care device that can be used to screen for AD.

Original languageEnglish
Pages (from-to)61-66
Number of pages6
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume1
Issue number1
DOIs
StatePublished - 1 Jan 2015

Fingerprint

Alzheimer Disease
Neuropsychological Tests
Linear Models
Point-of-Care Systems
Aptitude
Hematologic Tests
Biomarkers
Equipment and Supplies
Serum
Research

Keywords

  • Alzheimer's disease
  • Biomarkers
  • Diagnosis
  • Verbal fluency

Cite this

@article{84eec63a7f324db2ae3ffd3b1f26d108,
title = "Molecular markers of neuropsychological functioning and Alzheimer's disease",
abstract = "Background: The current project sought to examine molecular markers of neuropsychological functioning among elders with and without Alzheimer's disease (AD) and determine the predictive ability of combined molecular markers and select neuropsychological tests in detecting disease presence. Methods: Data were analyzed from 300 participants (n=150, AD and n=150, controls) enrolled in the Texas Alzheimer's Research and Care Consortium. Linear regression models were created to examine the link between the top five molecular markers from our AD blood profile and neuropsychological test scores. Logistical regressions were used to predict AD presence using serum biomarkers in combination with select neuropsychological measures. Results: Using the neuropsychological test with the least amount of variance overlap with the molecular markers, the combined neuropsychological testandmolecular markers was highly accurate in detecting AD presence. Conclusion: This work provides the foundation for the generation of a point-of-care device that can be used to screen for AD.",
keywords = "Alzheimer's disease, Biomarkers, Diagnosis, Verbal fluency",
author = "Melissa Edwards and Balldin, {Valerie Hobson} and James Hall and Sidney O'Bryant",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.dadm.2014.11.001",
language = "English",
volume = "1",
pages = "61--66",
journal = "Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring",
issn = "2352-8729",
publisher = "Elsevier BV",
number = "1",

}

Molecular markers of neuropsychological functioning and Alzheimer's disease. / Edwards, Melissa; Balldin, Valerie Hobson; Hall, James; O'Bryant, Sidney.

In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 1, No. 1, 01.01.2015, p. 61-66.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Molecular markers of neuropsychological functioning and Alzheimer's disease

AU - Edwards, Melissa

AU - Balldin, Valerie Hobson

AU - Hall, James

AU - O'Bryant, Sidney

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background: The current project sought to examine molecular markers of neuropsychological functioning among elders with and without Alzheimer's disease (AD) and determine the predictive ability of combined molecular markers and select neuropsychological tests in detecting disease presence. Methods: Data were analyzed from 300 participants (n=150, AD and n=150, controls) enrolled in the Texas Alzheimer's Research and Care Consortium. Linear regression models were created to examine the link between the top five molecular markers from our AD blood profile and neuropsychological test scores. Logistical regressions were used to predict AD presence using serum biomarkers in combination with select neuropsychological measures. Results: Using the neuropsychological test with the least amount of variance overlap with the molecular markers, the combined neuropsychological testandmolecular markers was highly accurate in detecting AD presence. Conclusion: This work provides the foundation for the generation of a point-of-care device that can be used to screen for AD.

AB - Background: The current project sought to examine molecular markers of neuropsychological functioning among elders with and without Alzheimer's disease (AD) and determine the predictive ability of combined molecular markers and select neuropsychological tests in detecting disease presence. Methods: Data were analyzed from 300 participants (n=150, AD and n=150, controls) enrolled in the Texas Alzheimer's Research and Care Consortium. Linear regression models were created to examine the link between the top five molecular markers from our AD blood profile and neuropsychological test scores. Logistical regressions were used to predict AD presence using serum biomarkers in combination with select neuropsychological measures. Results: Using the neuropsychological test with the least amount of variance overlap with the molecular markers, the combined neuropsychological testandmolecular markers was highly accurate in detecting AD presence. Conclusion: This work provides the foundation for the generation of a point-of-care device that can be used to screen for AD.

KW - Alzheimer's disease

KW - Biomarkers

KW - Diagnosis

KW - Verbal fluency

UR - http://www.scopus.com/inward/record.url?scp=84938695468&partnerID=8YFLogxK

U2 - 10.1016/j.dadm.2014.11.001

DO - 10.1016/j.dadm.2014.11.001

M3 - Article

VL - 1

SP - 61

EP - 66

JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

SN - 2352-8729

IS - 1

ER -